🇺🇸 FDA
Pipeline program

cyclosporine

ASCT0031

Phase 3 small_molecule completed

Quick answer

cyclosporine for Graft Versus Host Disease is a Phase 3 program (small_molecule) at Children's Hospital of Fudan University with 1 ClinicalTrials.gov record(s).

Program details

Company
Children's Hospital of Fudan University
Indication
Graft Versus Host Disease
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials